# Effect of Icosapent-ethyl Ester (IPE) to Reduce the Residual Risk Cardiovascular Disease.

> **NCT06720662** · NA · NOT_YET_RECRUITING · sponsor: **University of Sao Paulo** · enrollment: 294 (estimated)

## Conditions studied

- Atherosclerosis Cardiovascular Disease

## Interventions

- **DIETARY_SUPPLEMENT:** Icosapent-ethyl ester capsules
- **DIETARY_SUPPLEMENT:** Corn oil Control

## Key facts

- **NCT ID:** NCT06720662
- **Lead sponsor:** University of Sao Paulo
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04-01
- **Primary completion:** 2025-12-30
- **Final completion:** 2026-01-30
- **Target enrollment:** 294 (ESTIMATED)
- **Last updated:** 2024-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06720662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06720662, "Effect of Icosapent-ethyl Ester (IPE) to Reduce the Residual Risk Cardiovascular Disease.". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT06720662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*